Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Takeda reports MIP-1alpha/RANTES receptor antagonists

Sep. 11, 1997

Bayer discloses inhibitors of leukotriene synthesis

Sep. 10, 1997

Inflazyme contracts Inveresk Research for IND support

Sep. 9, 1997

Celltech prepares improved PDE IV inhibitors

Sep. 8, 1997

Licensing agreement signed for OxSODrol

Sep. 5, 1997

Merck's asthma treatment receives first approvals

Sep. 4, 1997

Celltech prepares PDE IV inhibitors

Sep. 4, 1997

Sepracor's levalbuterol NDA accepted by FDA

Sep. 4, 1997

LT antagonist/antihistamine combination highly effective against EAR/LAR

Sep. 3, 1997

ET antagonists for asthma

Sep. 2, 1997

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...